Literature DB >> 26810028

Synthesis and Antimicrobial Screening of Novel Thioglycosides and Acyclonucleoside Analogs Carrying 1,2,3-Triazole and 1,3,4-Oxadiazole Moieties.

M R Aouad1,2.   

Abstract

The solvent-free 1,3-dipolar cycloaddition reaction of dimethylacetylene dicarboxylate (1) with 2-chlorophenyl azide (2) afforded 1,2,3-triazole diester 3 that upon hydrazinolysis, furnished the corresponding bis-acid hydrazide 4. The treatment of compound 4 with carbon disulfide in a refluxing potassium hydroxide solution furnished the desired bis-1,3,4-oxadiazole-2-thione 5 tethered to a 1,2,3-triazole moiety. The respective SOx-glycosides 9-11 were obtained by glycosylation of bis-oxadiazole 5 with 2,3,4,6-tetra-O-acetyl-α-d-glucopyranosyl bromide (6), 2,3,4,6-tetra-O-acetyl-α-d-galactopyranosyl bromide (7), and 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-α-d-glucopyranosyl chloride (8) in dry acetone in the presence of Et3N, which acted as a base. However, alkylation of 5 with halogeno-alkanol 12 or 13, chloroglycerol 14, bromoethers 20 or 21, and epichlohydrin 22 in the presence of K2CO3 in DMF yielded the corresponding acyclonucleoside analogs 16-18 and 23-25. The isopropylidenes 19 and acetyl derivatives 26-28 of the products were also prepared. The newly synthesized compounds were characterized by (1)H NMR, (13)C NMR, 2D NMR, and mass spectra. The compounds were screened for their antibacterial and antifungal activities. A number of the tested compounds exhibited significant antimicrobial activity compared to the reference drugs.

Entities:  

Keywords:  1,2,3-Triazoles; 1,3,4-oxadiazoles; acyclonucleoside analogs; antimicrobial activity; thioglycosides

Mesh:

Substances:

Year:  2016        PMID: 26810028     DOI: 10.1080/15257770.2015.1109098

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  6 in total

1.  Synthesis, Characterization and Nanoformulation of Novel Sulfonamide-1,2,3-triazole Molecular Conjugates as Potent Antiparasitic Agents.

Authors:  Faizah S Aljohani; Nadjet Rezki; Mohamed R Aouad; Bassma H Elwakil; Mohamed Hagar; Eman Sheta; Nermine Mogahed Fawzy Hussein Mogahed; Sanaa K Bardaweel; Nancy Abd-Elkader Hagras
Journal:  Int J Mol Sci       Date:  2022-04-11       Impact factor: 6.208

2.  Design and Synthesis of Novel Imidazole Derivatives Possessing Triazole Pharmacophore with Potent Anticancer Activity, and In Silico ADMET with GSK-3β Molecular Docking Investigations.

Authors:  Fawzia Al-Blewi; Salma Akram Shaikh; Arshi Naqvi; Faizah Aljohani; Mohamed Reda Aouad; Saleh Ihmaid; Nadjet Rezki
Journal:  Int J Mol Sci       Date:  2021-01-25       Impact factor: 5.923

3.  Design, synthesis, in silico and in vitro antimicrobial screenings of novel 1,2,4-triazoles carrying 1,2,3-triazole scaffold with lipophilic side chain tether.

Authors:  Mohamed Reda Aouad; Mariem Mohammed Mayaba; Arshi Naqvi; Sanaa K Bardaweel; Fawzia Faleh Al-Blewi; Mouslim Messali; Nadjet Rezki
Journal:  Chem Cent J       Date:  2017-11-21       Impact factor: 4.215

4.  Design, Synthesis and Anticancer Screening of Novel Benzothiazole-Piperazine-1,2,3-Triazole Hybrids.

Authors:  Mohamed R Aouad; Moataz A Soliman; Muath O Alharbi; Sanaa K Bardaweel; Pramod K Sahu; Adeeb A Ali; Mouslim Messali; Nadjet Rezki; Yaseen A Al-Soud
Journal:  Molecules       Date:  2018-10-27       Impact factor: 4.411

5.  Design, synthesis, ADME prediction and pharmacological evaluation of novel benzimidazole-1,2,3-triazole-sulfonamide hybrids as antimicrobial and antiproliferative agents.

Authors:  Fawzia Faleh Al-Blewi; Meshal A Almehmadi; Mohamed Reda Aouad; Sanaa K Bardaweel; Pramod K Sahu; Mouslim Messali; Nadjet Rezki; El Sayed H El Ashry
Journal:  Chem Cent J       Date:  2018-11-01       Impact factor: 4.215

6.  8-Hydroxyquinoline Glycoconjugates Containing Sulfur at the Sugar Anomeric Position-Synthesis and Preliminary Evaluation of Their Cytotoxicity.

Authors:  Monika Krawczyk; Gabriela Pastuch-Gawołek; Agnieszka Hadasik; Karol Erfurt
Journal:  Molecules       Date:  2020-09-11       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.